Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01100944
What this trial is testing

PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT03699111
What this trial is testing

Identification of New Patient Stratification Tools in MSS RAS mt mCRC

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 29
Large-scale testing (Phase 3)Looking for participantsNCT06765109
What this trial is testing

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Who this might be right for
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive
Nuvalent Inc. 450
Early research (Phase 1)Looking for participantsNCT06241898
What this trial is testing

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 300
Large-scale testing (Phase 3)UnknownNCT06110663
What this trial is testing

HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 314
Early research (Phase 1)Looking for participantsNCT07252414
What this trial is testing

GenSci143 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469306
What this trial is testing

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT01729884
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more
University of Washington 3
Testing effectiveness (Phase 2)Study completedNCT04212052
What this trial is testing

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT06127238
What this trial is testing

Study of ST-1898 in Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 90
Early research (Phase 1)UnknownNCT04856371
What this trial is testing

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Haihe Biopharma Co., Ltd. 228
Early research (Phase 1)UnknownNCT05461287
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 290
Not applicableUnknownNCT02577263
What this trial is testing

Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Pontificia Universidad Catolica de Chile 64
Large-scale testing (Phase 3)Ended earlyNCT00503321
What this trial is testing

Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma

Who this might be right for
Gastric Cancer
Eastern Network of Cancer Immunological Therapy, Japan 13
Testing effectiveness (Phase 2)Looking for participantsNCT06840821
What this trial is testing

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Who this might be right for
Advanced Solid Tumors
Mainline Biosciences (Shanghai) Co., Ltd 156
Testing effectiveness (Phase 2)Study completedNCT00492206
What this trial is testing

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh 40
Early research (Phase 1)Study completedNCT00480584
What this trial is testing

A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT01267084
What this trial is testing

Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Who this might be right for
Neoplasm Metastases
Janssen Research & Development, LLC 12
Testing effectiveness (Phase 2)WithdrawnNCT00386399
What this trial is testing

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT04172532
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 92
Next Page